20 May 2013
Keywords: NanoViricides, FuCide, influenza drug candidates, Tamiflu
Article | 21 August 2012
US drug developer NanoViricides (OTCBB: NNVC) says that anti-influenza drug candidates under its FluCide program, when given orally, were nearly ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 August 2012
20 August 2012
© 2013 thepharmaletter.com